Sort
261,768 grants matching “gene therapy”
SPORE: Brain Tumore SPORE Grant
$2,161,996Mitchel S. Berger · University Of California, San Francisco · P50 · FY2014 · CA
SPORE in Skin Cancer
$2,161,838John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$2,161,658Marina Caskey · Rockefeller University · U01 · FY2020 · AI
Phase lll Study of the Effects of Selenium on Ademonas
$2,161,546M. Peter Lance · University Of Arizona · P01 · FY2008 · CA
UCLA SPORE in Brain Cancer
$2,161,493Linda M Liau · University Of California Los Angeles · P50 · FY2025 · CA
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
$2,161,448Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Recombinant Adeno Associated Virus
$2,161,260Robert Kotin · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
PICS: A New Horizon for Surgical Critical Care
$2,161,178Frederick A Moore · University Of Florida · P50 · FY2017 · GM
GENETIC APPROACHES TO EARLY CARDIAC DEVELOPMENT
$2,161,136Robert Schwartz · Texas A&M University Health Science Ctr · P01 · FY2007 · HL
Early Events in Alzheimer Pathogenesis
$2,161,123Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2016 · AG
Gene Therapy for Leber Congenital Amaurosis
$2,160,789University Of Florida · U10 · FY2001 · EY
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
$2,160,774Boro Dropulic · Lentigen Corporation · R44 · FY2011 · CA
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease
$2,160,049Marlene Rabinovitch · Stanford University · U01 · FY2015 · HL
Head and Neck Cancer SPORE at the University of Wisconsin
$2,160,041Paul M Harari · University Of Wisconsin-Madison · P50 · FY2020 · DE
Disease mechanism and therapies for retinal degeneration
$2,160,041Tiansen Li · National Eye Institute · ZIA · FY2025 · EY
The Alzheimer's Disease Research Center at the University of California, Irvine
$2,159,993Frank M Laferla · University Of California-Irvine · P50 · FY2015 · AG
PPG - Gene Therapy for Cystic Fibrosis Lung Disease
$2,159,794Paul B McCray · University Of Iowa · P01 · FY2013 · HL
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis
$2,159,793Athan Kuliopulos · Tufts Medical Center · P50 · FY2012 · HL
Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases
$2,159,135Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Cell-free DNA to detect transplant rejection
$2,159,104Sean Agbor-Enoh · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Selective Targeting of Pancreatic Cancer SPORE
$2,158,912Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
DEVELOPMENT OF A NOVEL DRUG CANDIDATE WITH A FIRST-in-CLASS MECHANISM FOR SMOKING CESSATION, RELAPSE and ABSTINENCE
$2,158,836Nurulain T Zaveri · Astraea Therapeutics, Llc · U01 · FY2019 · DA
Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors
$2,158,500John K Hewitt · University Of Colorado · P60 · FY2011 · DA
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
$2,158,273Jean-Pierre J Issa · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$2,158,015Roger L Shapiro · Harvard School Of Public Health · U01 · FY2019 · AI